MCLEAN, Va. – As Americans are stranded in the Middle East amid the U.S. and Israel war with Iran, government and private agencies are working around the clock to conduct evacuations. In addition to the…
admin
-
-
-
Vital Metals Limited (ASX: VML) (“Vital Metals” or “the Company”) is pleased to report final overlimit assay results from grab samples collected at Nechalacho, confirming exceptional rare earth grades of up to 292,145ppm TREO. Highlights:…
-
CALGARY, AB / ACCESS Newswire / March 9, 2026 / Valeura Energy Inc. (TSX:VLE,OTC:VLERF)(OTCQX:VLERF) (‘Valeura’ or the ‘Company’) announces completion of a successful infill drilling campaign at its Gulf of Thailand Manora field (Block G1/48,…
-
CALGARY, AB / ACCESS Newswire / March 9, 2026 / Valeura Energy Inc. (TSX:VLE,OTC:VLERF)(OTCQX:VLERF) (‘Valeura’ or the ‘Company’) acknowledges decrees pertaining to Thailand’s new fuel security measures, as signed by Thailand’s Prime Minister and published…
-
Here’s a quick recap of the crypto landscape for March 9 as of 9:00 a.m. UTC. Get the latest insights on Bitcoin, Ether and altcoins, along with a round-up of key cryptocurrency market news. Bitcoin…
-
Walker Lane Resources Ltd. (TSX-V: WLR) (Frankfurt: 6YL) (the ‘Company’) announces that the Company continues to work diligently toward the completion and filing of the Company’s annual audited financial statements and management’s discussion and analysis…
-
Investing
Skyharbour JV Partner Denison Mines Commences Winter Drill Program at the Wheeler North Joint Venture in Northern Saskatchewan
by adminSkyharbour Resources Ltd. (TSX-V:SYH) (OTCQX:SYHBF) (Frankfurt:SC1P) (‘Skyharbour’, ‘SYH’ or the ‘Company’) is pleased to announce that its joint venture partner, Denison Mines Corp. (‘Denison’) (TSX:DML) (NYSE American: DNN), has commenced the 2026 winter exploration program at the…
-
Oreterra Metals Corp. (TSXV: OTMC,OTC:OTMCF) (OTCID: OTMCF) (FSE: D4R0) (WKN: A421RQ) (‘Oreterra’ or the ‘Company’) announces the granting of stock options to directors and officers to purchase an aggregate of 4,507,750 common shares of the…
-
Investing
InMed Provides Update on Pharmaceutical Development Programs – Advancing Lead Drug Candidates Towards IND and Clinical Trial
by adminAdvancing Alzheimer’s and Age-Related Macular Degeneration Programs Toward FDA Engagement and IND-Enabling Activities Targeting Initiation of Phase 1 Clinical Trial in Alzheimer’s Disease in 2027 InMed Pharmaceuticals Inc. (NASDAQ: INM) (‘InMed’ or the ‘Company’), a…
